Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: Pharmacokinetic considerations

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 3, 2009, Pages 1006-1015

  Fantegrossi, William E ^a,b   Murai, Naoki ^b,c   Mathúna, Brian Ó ^c   Pizarro, Nieves ^c   De La Torre, Rafael ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b EMORY UNIVERSITY   (United States)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISCRIMINATION; ENANTIOMER; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; SINGLE DRUG DOSE;

ANIMALS; BEHAVIOR, ANIMAL; DISCRIMINATION LEARNING; HALLUCINOGENS; MALE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REINFORCEMENT (PSYCHOLOGY); STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 66749120158     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.150573     Document Type: Article

References (34)

1. Agranat II and Caner H (1999) Intellectual property and chirality of drugs. Drug Discov Today 7:313-321. (Pubitemid 29292399)
2. Bondareva T, Wesołowska A, Dukat M, Lee M, Young R, and Glennon RA (2005) S(+)- and R(-) N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine. Pharmacol Biochem Behav 82:531-538. (Pubitemid 41827596)
3. Chu T, Kumagai Y, DiStefano EW, and Cho AK (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51:789-796. (Pubitemid 26094447)
4. Cole JC, Bailey M, Sumnall HR, Wagstaff GF, and King LA (2002) The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 97:1531-1536.
5. de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, and Camí J (2000) Non-linear pharmacokinetics of MDMA ("ecstasy") in humans. Br J Clin Pharmacol 49:104-109. (Pubitemid 30068287)
6. Evans SM and Johanson CE (1986) Discriminative stimulus properties of (±)-3,4-methylenedioxymethamphetamine and (±)-3,4- methylenedioxyamphetamine in pigeons. Drug Alcohol Depend 18:159-164. (Pubitemid 16002931)
7. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, and Woods JH (2003) Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166:202-211. (Pubitemid 36384765)
8. Fantegrossi WE, Kiessel CL, De la Garza R 2nd, and Woods JH (2005) Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. Psychopharmacology 181:529-536.
9. Fitzgerald RL, Blanke RV, Glennon RA, Yousif MY, Rosecrans JA, and Poklis A (1989) Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood. J Chromatogr 490:59-69. (Pubitemid 19127976)
10. Glennon RA (1989) Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships. NIDA Res Monogr 94:43-67. (Pubitemid 20091160)
11. Glennon RA, Little PJ, Rosecrans JA, and Yousif M (1987) The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice. Pharmacol Biochem Behav 26:425-426. (Pubitemid 17038131)
12. Glennon RA, Titeler M, and Young R (1986) Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies. Psychopharmacol Bull 22:953-958. (Pubitemid 17183412)
13. Glennon RA, Young R, Rosecrans JA, and Anderson GM (1982) Discriminative stimulus properties of MDA analogs. Biol Psychiatry 17:807-814. (Pubitemid 12048365)
14. Goodwin AK and Baker LE (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (±)-MDMA in rats. Exp Clin Psychopharmacol 8:415-423.
15. Herin DV, Liu S, Ullrich T, Rice KC, and Cunningham KA (2005) Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology 178:505-513. (Pubitemid 40486991)
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
17. Johanson CE, Kilbey M, Gatchalian K, and Tancer M (2006) Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. Drug Alcohol Depend 81:27-36. (Pubitemid 41682476)
18. Kamien JB, Johanson CE, Schuster CR, and Woolverton WL (1986) The effects of (±)-methylenedioxymethamphetamine and (±)- methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline. Drug Alcohol Depend 18:139-147. (Pubitemid 16002929)
19. Koek W, Carter LP, Wu H, Coop A, and France CP (2006) Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gammabutyrolactone. Behav Pharmacol 17:239-247.
20. Li JX, McMahon LR, Gerak LR, Becker GL, and France CP (2008) Interactions between delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception. Psychopharmacology 199:199-208.
21. Lim HK, Su Z, and Foltz RL (1993) Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 22:403-411. (Pubitemid 23187115)
22. Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, and Ricaurte GA (2006) Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology 31:339-350. (Pubitemid 43113398)
23. Mueller M, Peters FT, Maurer HH, McCann UD, and Ricaurte GA (2008) Nonlinear pharmacokinetics of (±)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J Pharmacol Exp Ther 327:38-44.
24. Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens: identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305-313.
25. Nichols DE and Oberlender R (1990) Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs? Ann N Y Acad Sci 600:613-623; discussion 623-625.
26. Oberlender R and Nichols DE (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology 95:71-76.
27. Ortuño J, Pizarro N, Farré M, Mas M, Segura J, Camí J, Brenneisen R, and de la Torre R (1999) Quantification of 3,4- methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection. J Chromatogr B Biomed Sci Appl 723:221-232. (Pubitemid 29148125)
28. Partilla JS, Dempsey AG, Nagpal AS, Blough BE, Baumann MH, and Rothman RB (2006) Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J Pharmacol Exp Ther 319:237-246. (Pubitemid 44455128)
29. Pizarro N, Llebaria A, Cano S, Joglar J, Farré M, Segura J, and de la Torre R (2003) Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 17:330-336. (Pubitemid 36193672)
30. Reist M, Carrupt PA, Francotte E, and Testa B (1998) Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites. Chem Res Toxicol 11:1521-1528. (Pubitemid 29013628)
31. Schechter MD (1987) MDMA as a discriminative stimulus: isomeric comparisons. Pharmacol Biochem Behav 27:41-44. (Pubitemid 17096838)
32. Wegel RL and Lane CE (1924) The auditory masking of one pure tone by another and its probable relation to the dynamics of the inner ear. Physiol Rev 23:266-285.
33. Yarosh HL, Katz EB, Coop A, and Fantegrossi WE (2007) MDMA-like behavioral effects of N-substituted piperazines in the mouse. Pharmacol Biochem Behav 88:18-27. (Pubitemid 47381540)
34. Young R and Glennon RA (2008) MDMA (N-methyl-3,4- methylenedioxyamphetamine) and its stereoisomers: similarities and differences in behavioral effects in an automated activity apparatus in mice. Pharmacol Biochem Behav 88:318-331. (Pubitemid 350116259)